|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| BioCompuTech | ||||||||||||||||
| September 06, 2002 | ||||||||||||||||
|
IIR, Cambridge 9th - 11th Dec 02 Conference Day One Monday 9th December 9:00 Registration and coffee 9:30 Opening remarks from the Chair Dr Charlie Hodgman, Senior Informatics Leader, GlaxoSmithKline From genes to proteins to proteomics 9:40 Keynote Address: Where are we at in the postgenomics era? Professor Sydney Brenner Distinguished Professor The Salk Institute 10:10 Managing collection, analysis and interpretation of data from functional genomics and proteomics David Lovell Associate Director, European Head of Statistical Support to Clinical Pharmacogenomics Pfizer Global Research and Development 10:40 Using genomics and bioinformatics for drug discovery Dr Tim Bonnert Molecular Biology and Bioinformatics Merck Sharpe and Dohme 11:00 Morning refreshments 11:40 Using Compugen's oligo libraries product: an application of Compugen's LEADS technology Bauke Ylstra Micro Array Facility Free University Medical Center (VUMC) 12:10 High Throughput Drug Target Identification in the Post-Genomic Era Raveh Gill-More VP Marketing, BioApplications division Compugen 12:40 Lunch 14:00 Selecting and validating druggable targets starting with proteome-wide analyses Dr Malcolm Weir Chief Executive Officer InPharmatica 14:30 A consensus procedure for predicting the location of alpha-helical transmembrane segments in proteins. Dr Luis Parodi Experimental Medicine Pharmacia and Upjohn 15:00 Shaping Biological Knowledge Dr. Frédérique Lisacek Chief Scentific Officer GeneBio SA 15:20 Afternoon tea and opportunity to visit the exhibition 16:00 Bacterial Artificial Chromosome clones as enabling tools for genomics, diagnostics, gene-discovery and haplotype characterization Pieter J. de Jong Principal Investigator, BACPAC Resourcesr Children's Hospital Oakland Research Institute 16:30 Microbial evolution against the marketing forces of the pharmaceutical industry. Jean-Michel Claverie Director, Structural & Genetic Information Laboratory CNRS-Aventis Network pathways 17:00 T-Coffee, a novel method for combining biological information Professor Cédric Notredame Professor of BioInformatics CNRS/Swiss BioInformatics Institute 17:30 Methods for reconstructing gene networks from microarray data Dr Elvis Brazma DataMining and Visualisation EBI 18:00 An information-flow model to aid business strategy Dr Charlie Hodgman Senior Informatics Leader GlaxoSmithKline 18:30 Cocktail Reception and opportunity to visit the exhibition End of day one Conference Day Two Tuesday 10th December 8:30 Registration & Coffee 9:00 Opening remarks from the chair Dr Alan Williamson Consultant Abingworth Management 9:10 Gaining biological insight from genomics and proteomics using PathwayPrism Jonathan Levin President and Chief Executive Officer Physiome 9:40 Handling SNPs and haplotypes and relating that to disease prediction Rick Woychik Chief Scientific Officer Lynx Therapeutics Target Validation 10:10 Structure-based Screening and Design in Drug Discovery Mats Wikström Head of the Macromolecular Structure Laboratory Biovitrum, SE-112 87 Stockholm, Sweden 10:40 Morning coffee and opportunity to visit the exhibition 11:20 The use of physiological simulation in drug discovery and development Denis Noble University Laboratory of Physiology University of Oxford 11:50 Down on the farm – Industrialisation of in silico drug discovery Richard Scott Head of Chemoinformatics De Novo Pharmaceuticals 12:20 Identification of protein targets and biomarkers in human therapeutics Karoly Nicolich Founder and Chief Executive Officer AGY Inc. 12:50 Lunch 14:10 Looking for Leads in the Genomics Age: From Target Class Design to Deck Selection Andrew Good Principal Scientist Bristol Myers Squibb Data Mining and Business Strategy 14:40 Keynote Address: Bioinformatics – at the heart of the new biology Janet Thornton Director EBI 15:10 Context-Driven Decision Making in Life Science R&D Dr Steve Gardner Vice-President and Chief Technical Officer Viaken Systems Ltd 15:50 Afternoon tea and opportunity to visit the exhibition 16:20 Keynote Address: Finding Disease Genes Using Automated Mass Spectrometry Dr Charles Cantor Chief Scientific Officer Sequenom 17:00 Relational data mining for functional genomics Dr Walter Luyten Chief Scientific Officer PharmaDM 17:30 The Use of Ontologies in Information Retrieval for Drug Discovery Dr Julie Barnes Chief Scientific Officer BioWisdom 18:00 Drug discovery aspects of genomics and bioinformatics: the business/alliance side of things Henri Theunissen, Organon 18:30 Cocktail Reception and opportunity to visit the exhibition End of day two Workshop A 11th December 2002 DATAMINIG This Workshop Will Begin At 2pm On The 11th December And Will End By 5.30pm. Refreshments Will Be Provided WHY YOU CANNOT AFFORD TO MISS THIS WORKSHOP The successful analysis of data and the ability to detect and convert patterns into knowledge depends on the convergence of information technology with life sciences research and development. Data mining plays an important role in the data and knowledge management processes of Life Science-based companies. By utilising the right data mining tools, you can gain valuable information from the oceans of data relating to areas such as gene sequencing, expression analysis, functional genomics, structural biology or protein structure, and observe unexpected and often critical patterns. In this workshop we will explore unique ways to mine your data in the most effective manner, and how to tie the data mining process and tools in with your overall data and knowledge management requirements. The agenda will cover the following main areas: · An overview of the data challenges in Life Sciences and the role data mining plays in a Life Science-based company’s overall IT framework · Presentations, demonstrations and case studies exploring the unique ways of getting the most out of your data · Tools to get you started on the path toward more effective data mining and management in the areas of data federation, information mining, and federated mining · Real-time problem solving with the ability to ask questions of the data experts from IBM Negotiating the Bioinformatics IP minefield Patents and Licensing This Workshop Will Begin At 2pm On The 11th December And Will End By 5.30pm. Refreshments Will Be Provided WHY YOU CANNOT AFFORD TO MISS THIS WORKSHOP Significant investments continue to be made in the development of micro-array technology, sequencing of genomes and proteomes as well as the devising of algorithms at the heart of data mining and manipulation software. Often scant attention is paid to the protection of the inventions and data produced in those efforts. There is much talk of filing patents, but often other valuable intellectual property rights such as database rights, copyright and confidential information are overlooked. Even in the patent field there is much misunderstanding as to the differences in the patentability of software and gene sequence based inventions, including the differences between the US and Europe in this respect. WORKSHOP AGENDA The first half of the workshop will be presented by Alex Wilson, Senior Associate of the Bioinformatics Group of the specialist IP law firm Bristows. The focus will be on developing internal practices for protecting valuable IP which take into account the differences in protection available in the US, Europe and Japan. The session will also consider freedom to operate issues, using the genomics field as an example and the possible approaches which can be adopted to mitigate the impact of royalty stacking. The second half of the workshop will be presented by Matthew Warren, a Partner at Bristows who specialises in advising on R&D collaborations and licensing transactions in the biopharma sector. This part of the workshop will focus on reach-through licensing, competition law issues, consequences of loss of patent protection, evidence of use of licensed technology and competing products. |
||||||||||||||||
| Organized by: | IIR | |||||||||||||||
| Invited Speakers: | With Keynote Speakers • Prof. Sydney Brenner, Distinguished Professor, The Salk Institute • Dr Charles Cantor, Chief Scientific Officer, Sequenom • Prof. Klaus Lindpaintner, Head of Roche Genetics, F. Hoffmann-La Roche • Prof. Janet Thornton, Director, European Bioinformatics Institute • Plus over 30 other international experts... |
|||||||||||||||
| Deadline for Abstracts: | n/a | |||||||||||||||
| Registration: | www.biocomputech.com | |||||||||||||||
| E-mail: | pheigl@iirltd.co.uk | |||||||||||||||
| Posted by: | Vicki Ansell | |||||||||||||||
| Host: | 193.133.64.179 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||